Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
Willemien J. van Driel(The Netherlands Cancer Institute), Gabe S. Sonke(Oncode Institute), Harm van Tinteren(Princess Máxima Center), Karolina Sikorska(Dutch Cancer Society), Jacobien M. Kieffer(Norwegian Womens Public Health Association), Leon F.A.G. Massuger(Radboud University Nijmegen), Simone N. Koole(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), Henk W.R. Schreuder(Gynecologic Oncology Group), Ignace H. J. T. de Hingh(Radboud University Nijmegen), Victor J. Verwaal(The Netherlands Cancer Institute), Jules H. Schagen van Leeuwen(Holy Family Hospital), Jacobus van der Velden(Amsterdam UMC Location University of Amsterdam), Neil K. Aaronson(The Netherlands Cancer Institute), Arend G. J. Aalbers(The Netherlands Cancer Institute), Ralph H.M. Hermans(Gynecologic Oncology Group), Henriëtte J.G. Arts(Gynecologic Oncology Group), Koen Van de Vijver(Cancer Prevention Institute of California)
Cited by 1,407
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k